# FDA Inspection 1261644 - Carvi, LLC - January 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/carvi-llc/6d58143d-e5cd-482c-b3b8-06f853d88605
Source feed: FDA_Inspections

> FDA Inspection 1261644 for Carvi, LLC on January 28, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261644
- Company Name: Carvi, LLC
- Inspection Date: 2025-01-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261644 - 2025-01-28](https://www.keypedia.com/records/fda_inspections/carvi-llc/c0d5e8f9-537d-449c-88ea-51de3dca0026)
- [FDA Inspection 1020886 - 2017-08-08](https://www.keypedia.com/records/fda_inspections/carvi-llc/9078243f-6139-4591-9128-19d01ab93f7d)
- [FDA Inspection 865390 - 2014-01-27](https://www.keypedia.com/records/fda_inspections/carvi-llc/38414793-973a-4bc9-982a-1924ad901990)

Company: https://www.keypedia.com/companies/carvi-llc/f24c47c1-377c-4927-9ceb-43db8e354a5b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d